Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase NA 2Phase 1/2 2Phase 4 1Phase 2/3 1Phase 1 1

Status

Completed 6Not yet recruiting 4Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 4Lymphoid 1

Conditions

Multiple Myeloma 12Recurrence 9Neoplasms 8Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Colorectal Neoplasms 7Pancreatic Neoplasms 6Lymphoma, B-Cell 6Carcinoma, Hepatocellular 6Breast Neoplasms 6Sarcoma 5Prostatic Neoplasms 5Lymphoma 5Burkitt Lymphoma 5Neoplasms, Plasma Cell 4Myasthenia Gravis 4Lung Neoplasms 4Glioblastoma 4Brain Neoplasms 4Stomach Neoplasms 3Solid Tumor 3Pituitary Neoplasms 3Ovarian Neoplasms 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumors 3

Interventions

fludarabine 2Cyclophosphamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × Neoplasms, Plasma Cell × Clear all
NCT07586709 2026-05-14

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

Chinese PLA General Hospital

Phase EARLY_PHASE1 Not yet recruiting
18 enrolled
Plasma cell

Neoplasms, Plasma Cell

NCT07519187 2026-04-09

CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms

The General Hospital of Western Theater Command

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
Plasma cell

Recurrence, Neoplasms, Plasma Cell

NCT06986434 2026-04-08

CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation

Affiliated Hospital to Academy of Military Medical Sciences

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
LymphoidPlasma cell

Lymphoma, Recurrence, Neoplasms, Plasma Cell

NCT07077330 2025-07-22

CAR19BCMA

Chinese PLA General Hospital

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
Plasma cell

Recurrence, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡